test

Aryn Sands

@Bml Capital Management, Llc

Latest period2024 - Q3ReportedManaged Assets$169.95MTotal holdings29
Assets growth rate21.28%Assets growth rate (2-Q avg)6.84%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Bml Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Bml Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.95M in assets, with a quarterly growth rate of 21.28% and a 2-quarter average growth rate of 6.84%. The portfolio is managed by Aryn Sands, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AVIRAtea Pharmaceuticals Inc
Recent Activity
Increased 4.31%
13.11%
$22.277M
6.65M shares@ $3.35 avg price
ACRSAclaris Therapeutics Inc
Recent Activity
Increased 9.72%
9.65%
$16.387M
14.25M shares@ $1.15 avg price
ADVMAdverum Biotechnologies Inc
Recent Activity
Increased 15.37%
9.37%
$15.922M
2.268M shares@ $7.02 avg price
RPHMReneo Pharmaceuticals Inc
Recent Activity
Increased 29.39%
3.46%
$5.878M
3.457M shares@ $1.71 avg price
ORMPOramed Pharmaceuticals Inc
Recent Activity
Increased 62.06%
3.14%
$5.334M
2.186M shares@ $2.44 avg price
ACHLAchilles Therapeutics Plc
Recent Activity
Increased 555.82%
2.47%
$4.182M
4.1M shares@ $1.02 avg price
CNTBConnect Biopharma Hldgs Ltd
Recent Activity
Increased 2.45%
1.78%
$3.014M
2.093M shares@ $1.44 avg price
PMVPPmv Pharmaceuticals Inc
Recent Activity
Increased 28.98%
1.49%
$2.516M
1.689M shares@ $1.49 avg price
MISTMilestone Pharmaceuticals In
Recent Activity
Increased 3.01%
1.02%
$1.727M
1.136M shares@ $1.52 avg price
IKNAIkena Oncology Inc
Recent Activity
Increased 23.62%
0.74%
$1.251M
723,288 shares@ $1.73 avg price